Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies

OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database …, 2018 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

The mechanism, clinical efficacy, safety, and dosage regimen of atomoxetine for ADHD therapy in children: a narrative review

D Fu, DD Wu, HL Guo, YH Hu, Y Xia, X Ji… - Frontiers in …, 2022 - frontiersin.org
Atomoxetine, a selective norepinephrine (NE) reuptake inhibitor, was approved for attention
deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We …

Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease

JM Rorabaugh, T Chalermpalanupap, CA Botz-Zapp… - Brain, 2017 - academic.oup.com
Abstract See Grinberg and Heinsen (doi: 10.1093/brain/awx261) for a scientific commentary
on this article. Clinical evidence suggests that aberrant tau accumulation in the locus …

Amphetamine modestly improves Conners' continuous performance test performance in healthy adults

DA MacQueen, A Minassian, BL Henry… - Journal of the …, 2018 - cambridge.org
Objectives: Amphetamine improves vigilance as assessed by continuous performance tests
(CPT) in children and adults with attention deficit hyperactivity disorder (ADHD). Less is …

Differential long-term medication impact on executive function and delay aversion in ADHD

B Rubio Morell… - Applied Neuropsychology …, 2019 - Taylor & Francis
The objective was to compare long-term effects of methylphenidate (MPH) and atomoxetine
(ATX) on executive functions (EF) and delay aversion (DAv) in ADHD. A randomized …

Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH) versus atomoxetine on executive function improvement and clinical effectiveness in …

Y Taş Torun, Y Işik Taner, E Güney… - Applied …, 2022 - Taylor & Francis
Objectives The aim of this study to compare the clinic efficacy and effects of osmotic release
oral system-methylphenidate and atomoxetine on executive function in children and …

Executive Function Problems and Treatment in Children and Adolescents with Attention Deficit and Hyperactivity Disorder.

U Savcı, AE Tufan, Y Öztürk… - Current Approaches in …, 2019 - search.ebscohost.com
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder seriously
affecting home, school, and social functioning of children and adolescent. In recent years …

Dikkat Eksikliği ve Hiperaktivite Bozukluğu Tanılı Çocuk ve Ergenlerde Yürütücü İşlev Sorunları ve Tedavisi

U Savcı, AE Tufan, Y Öztürk… - Psikiyatride Güncel …, 2019 - dergipark.org.tr
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder seriously
affecting home, school, and social functioning of children and adolescent. In recent years …

Processing speed may improve earlier than response inhibition/interferens in children with ADHD-combined type receiving methylphenidate: a single-center study

FH Çetin, HA Güler, SA Ersoy… - Psychiatry and Clinical …, 2019 - Taylor & Francis
ABSTRACT OBJECTIVES: The aim of this study was to determine the order of improvement
in response inhibition, interference capacity, and processing speed in the Stroop test after …

Drug holidays may not affect processing speed while they may reduce beneficial effects on resistance to interference among children with treated with …

G Göl Özcan, Y Öztürk, M Sari, Y İmrek… - Nordic Journal of …, 2021 - Taylor & Francis
Objective This study aimed to investigate the effects of drug holidays during summer
vacations among children with attention deficit/hyperactivity disorder (ADHD) who were …